These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11682028)

  • 21. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study.
    Piscaglia F; Zironi G; Gaiani S; Mazziotti A; Cavallari A; Gramantieri L; Valgimigli M; Bolondi L
    Hepatology; 1999 Jul; 30(1):58-64. PubMed ID: 10385639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
    Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
    Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Christos P; Paraskevi K; Konstantinos P; Katsaraki A; Tsianos EV
    Dig Dis Sci; 2005 Oct; 50(10):1771-7. PubMed ID: 16187171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.
    Spahr L; Martin PY; Giostra E; Niederberger M; Lang U; Capponi A; Hadengue A
    J Investig Med; 2002 Mar; 50(2):116-24. PubMed ID: 11928940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemodynamic changes in portal hypertension: new insights in the pathogenesis and clinical implications.
    Michielsen PP; Pelckmans PA
    Acta Gastroenterol Belg; 1994; 57(2):194-205. PubMed ID: 8053307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis.
    Xu L; Carter EP; Ohara M; Martin PY; Rogachev B; Morris K; Cadnapaphornchai M; Knotek M; Schrier RW
    Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1110-5. PubMed ID: 11097630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD
    Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis.
    Kakumitsu S; Shijo H; Yokoyama M; Kim T; Akiyoshi N; Ota K; Kubara K; Okumura M; Inoue K
    Hepatology; 1998 Feb; 27(2):377-82. PubMed ID: 9462634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.
    Matei V; Rodríguez-Vilarrupla A; Deulofeu R; García-Calderó H; Fernández M; Bosch J; Garcia-Pagán JC
    J Hepatol; 2008 Aug; 49(2):192-7. PubMed ID: 18534709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic and splanchnic hemodynamic disturbances in conscious rats with experimental liver cirrhosis without ascites.
    Fernández-Muñoz D; Caramelo C; Santos JC; Blanchart A; Hernando L; López-Novoa JM
    Am J Physiol; 1985 Sep; 249(3 Pt 1):G316-20. PubMed ID: 4037082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A feasibility study to evaluate splanchnic arterial and venous hemodynamics by flow-sensitive 4D MRI compared with Doppler ultrasound in patients with cirrhosis and controls.
    Stankovic Z; Csatari Z; Deibert P; Euringer W; Jung B; Kreisel W; Geiger J; Russe MF; Langer M; Markl M
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):669-75. PubMed ID: 23411868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of nitric oxide synthase inhibition on portal pressure and azygos blood flow in patients with cirrhosis.
    Forrest EH; Jones AL; Dillon JF; Walker J; Hayes PC
    J Hepatol; 1995 Sep; 23(3):254-8. PubMed ID: 8550988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamics.
    Møller S; Gülberg V; Henriksen JH; Gerbes AL
    J Hepatol; 1995 Aug; 23(2):135-44. PubMed ID: 7499784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.
    Reverter E; Mesonero F; Seijo S; Martínez J; Abraldes JG; Peñas B; Berzigotti A; Deulofeu R; Bosch J; Albillos A; García-Pagán JC
    Am J Gastroenterol; 2015 Jul; 110(7):985-92. PubMed ID: 26077176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Portal and splanchnic hemodynamics after partial splenic embolization in cirrhotic patients with hypersplenism.
    Helaly AZ; Al-Warraky MS; El-Azab GI; Kohla MA; Abdelaal EE
    APMIS; 2015 Dec; 123(12):1032-9. PubMed ID: 26547369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased hepatic expression of nitric oxide synthase type II in cirrhotic rats.
    Wang H; Chen XP; Qiu FZ
    World J Gastroenterol; 2004 Jul; 10(13):1923-7. PubMed ID: 15222038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splanchnic and extrasplanchnic arterial hemodynamics in patients with cirrhosis.
    Iwao T; Oho K; Sakai T; Tayama C; Sato M; Nakano R; Yamawaki M; Toyonaga A; Tanikawa K
    J Hepatol; 1997 Nov; 27(5):817-23. PubMed ID: 9382968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
    Wiest R; Groszmann RJ
    Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of esophageal varices and spontaneous portal-systemic shunts on postprandial splanchnic hemodynamics.
    Siringo S; Piscaglia F; Zironi G; Sofia S; Gaiani S; Zammataro M; Bolondi L
    Am J Gastroenterol; 2001 Feb; 96(2):550-6. PubMed ID: 11232705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.
    Fernández M; García-Pagán JC; Casadevall M; Bernadich C; Piera C; Whittle BJ; Piqué JM; Bosch J; Rodés J
    Gastroenterology; 1995 May; 108(5):1487-95. PubMed ID: 7537235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.